Kazakhstan Medical Raw Materials Overseas Market Analysis Report
Kazakhstan's medical raw materials market has an import dependency of about 88%, with imports totaling approximately USD 380 million in 2024. China is the largest supplier, accounting for about 32%. Local production capacity is weak, and the government is promoting a pharmaceutical localization strategy. In 2024, China's global API exports reached around USD 46 billion, with exports to Kazakhstan growing steadily. Key risks include tenge exchange rate fluctuations, supply chain concentration, an
View Full Report